Payment overview · 2025
General Payments
$24.33
1 reported records · 1 companies
Healthcare provider profile · identity verified
Kenneth C Li, MD
Allopathic & Osteopathic Physicians|Internal Medicine · POPLAR BLUFF, MO · NPI 1407834096
Verified facts
What the public records show
CMS Open Payments records show Kenneth C Li, MD received $24.33 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 183 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $24.33 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $24.33 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $24.33 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $24.33 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 183 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
183 | 29 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Pantoprazole Sodium | Pantoprazole Sodium | 1049 | 138 |
| Atorvastatin Calcium | Atorvastatin Calcium | 926 | 147 |
| Gabapentin | Gabapentin | 817 | 85 |
| Potassium Chloride | Potassium Chloride | 804 | 107 |
| Losartan Potassium | Losartan Potassium | 768 | 121 |
| Levothyroxine Sodium | Levothyroxine Sodium | 751 | 97 |
| Furosemide | Furosemide | 662 | 109 |
| Amlodipine Besylate | Amlodipine Besylate | 620 | 91 |
| Famotidine | Famotidine | 614 | 77 |
| Metoprolol Tartrate | Metoprolol Tartrate | 596 | 89 |
| Lisinopril | Lisinopril | 589 | 74 |
| Metformin Hcl | Metformin Hcl | 523 | 69 |
| Omeprazole | Omeprazole | 519 | 102 |
| Eliquis | Apixaban | 513 | 55 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 410 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 386 | 69 |
| Metoprolol Succinate | Metoprolol Succinate | 341 | 59 |
| Glimepiride | Glimepiride | 312 | 45 |
| Naproxen | Naproxen | 308 | 49 |
| Clopidogrel | Clopidogrel Bisulfate | 274 | 56 |
| Montelukast Sodium | Montelukast Sodium | 265 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 260 | 62 |
| Carvedilol | Carvedilol | 241 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 236 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 229 | 27 |
| Donepezil Hcl | Donepezil Hcl | 217 | 36 |
| Simvastatin | Simvastatin | 199 | 40 |
| Citalopram Hbr | Citalopram Hydrobromide | 198 | 39 |
| Trazodone Hcl | Trazodone Hcl | 192 | 27 |
| Warfarin Sodium | Warfarin Sodium | 191 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 186 | 38 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 185 | 26 |
| Ozempic | Semaglutide | 183 | 29 |
| Buspirone Hcl | Buspirone Hcl | 182 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 182 | 26 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 177 | 17 |
| Allopurinol | Allopurinol | 173 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 172 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 172 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 171 | 23 |
| Sertraline Hcl | Sertraline Hcl | 167 | 24 |
| Atenolol | Atenolol | 150 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 147 | 16 |
| Estradiol | Estradiol | 146 | 21 |
| Tramadol Hcl | Tramadol Hcl | 143 | 38 |
| Memantine Hcl | Memantine Hcl | 142 | 24 |
| Lorazepam | Lorazepam | 141 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 140 | 11 |
| Mirtazapine | Mirtazapine | 136 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 135 | 31 |
| Cefdinir | Cefdinir | 132 | 85 |
| Spironolactone | Spironolactone | 117 | 16 |
| Pregabalin | Pregabalin | 116 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 115 | 22 |
| Meloxicam | Meloxicam | 113 | 25 |
| Celecoxib | Celecoxib | 111 | 24 |
| Ibuprofen | Ibuprofen | 109 | 23 |
| Oxybutynin Chloride | Oxybutynin Chloride | 107 | 12 |
| Olanzapine | Olanzapine | 104 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 98 | 16 |
| Alendronate Sodium | Alendronate Sodium | 97 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 97 | 22 |
| Amitriptyline Hcl | Amitriptyline Hcl | 94 | 15 |
| Divalproex Sodium Er | Divalproex Sodium | 93 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 93 | 11 |
| Lamotrigine | Lamotrigine | 92 | suppressed |
| Levetiracetam | Levetiracetam | 92 | suppressed |
| Risperidone | Risperidone | 91 | 14 |
| Jardiance | Empagliflozin | 89 | suppressed |
| Prednisone | Prednisone | 88 | 51 |
| Tizanidine Hcl | Tizanidine Hcl | 88 | 13 |
| Propranolol Hcl | Propranolol Hcl | 87 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 87 | 22 |
| Trulicity | Dulaglutide | 86 | 13 |
| Benztropine Mesylate | Benztropine Mesylate | 80 | suppressed |
| Ezetimibe | Ezetimibe | 80 | 12 |
| Lovastatin | Lovastatin | 78 | 18 |
| Dicyclomine Hcl | Dicyclomine Hcl | 77 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 73 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 72 | suppressed |
| Topiramate | Topiramate | 71 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 70 | 18 |
| Glipizide Er | Glipizide | 69 | 14 |
| Sucralfate | Sucralfate | 68 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 67 | 14 |
| Flecainide Acetate | Flecainide Acetate | 64 | suppressed |
| Mounjaro | Tirzepatide | 64 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 62 | suppressed |
| Digoxin | Digoxin | 61 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 60 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 60 | 12 |
| Primidone | Primidone | 60 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 59 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 59 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 59 | suppressed |
| Myrbetriq | Mirabegron | 58 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 57 | suppressed |
| Ondansetron Odt | Ondansetron | 57 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 57 | 38 |
| Bumetanide | Bumetanide | 55 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 55 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 55 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 54 | 12 |
| Amoxicillin | Amoxicillin | 50 | 40 |
| Ropinirole Hcl | Ropinirole Hcl | 50 | suppressed |
| Baclofen | Baclofen | 48 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 48 | 17 |
| Clonazepam | Clonazepam | 47 | suppressed |
| Xarelto | Rivaroxaban | 45 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 43 | 27 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 42 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 42 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 42 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 39 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 34 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 38 | suppressed |
| Prenatal Vitamin Plus Low Iron | Pnv,calcium 72/Iron/Folic Acid | 38 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | suppressed |
| Levofloxacin | Levofloxacin | 37 | 24 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 37 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 37 | suppressed |
| Cephalexin | Cephalexin | 35 | 30 |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Latanoprost | Latanoprost | 33 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 33 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | suppressed |
| Nystatin | Nystatin | 31 | 16 |
| Paxlovid | Nirmatrelvir/Ritonavir | 31 | 30 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 31 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 31 | 11 |
| Divalproex Sodium | Divalproex Sodium | 30 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 30 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 11 |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Gemfibrozil | Gemfibrozil | 28 | suppressed |
| Glipizide | Glipizide | 28 | suppressed |
| Telmisartan | Telmisartan | 28 | suppressed |
| Azithromycin | Azithromycin | 27 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 14 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 27 | 19 |
| Lidocaine | Lidocaine | 27 | suppressed |
| Brilinta | Ticagrelor | 26 | suppressed |
| Letrozole | Letrozole | 26 | suppressed |
| Phenytoin | Phenytoin | 26 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 26 | suppressed |
| Vascepa | Icosapent Ethyl | 26 | suppressed |
| Fluconazole | Fluconazole | 25 | 13 |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 25 | suppressed |
| Temazepam | Temazepam | 25 | suppressed |
| Loperamide | Loperamide Hcl | 24 | suppressed |
| Metronidazole | Metronidazole | 24 | 11 |
| Klor-Con M10 | Potassium Chloride | 23 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Cilostazol | Cilostazol | 21 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 21 | suppressed |
| Januvia | Sitagliptin Phosphate | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 14 |
| Promethazine Hcl | Promethazine Hcl | 19 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Alprazolam | Alprazolam | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Finasteride | Finasteride | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 17 | 17 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Metolazone | Metolazone | 17 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 17 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | 12 |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 15 | suppressed |
| Premarin | Estrogens, Conjugated | 15 | suppressed |
| Techlite Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 11 |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Sprintec | Norgestimate-Ethinyl Estradiol | 14 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 13 | suppressed |
| Nadolol | Nadolol | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Perphenazine | Perphenazine | 12 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Jantoven | Warfarin Sodium | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Triazolam | Triazolam | 11 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $24.33 · 1 records | Novo Nordisk Inc | Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error